(VEEV) Veeva Systems - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9224751084

VEEV: Cloud, Software, Analytics, Management, Solutions, Services

Veeva Systems Inc. (NYSE:VEEV) is a leader in cloud-based software solutions tailored for the life sciences industry, modernizing how pharmaceutical and biotechnology companies operate. Founded in 2007 and headquartered in Pleasanton, California, Veeva has established itself as a critical enabler of digital transformation in one of the most regulated and complex industries globally.

The company’s product portfolio is divided into two main categories: Veeva Commercial Cloud and Veeva Development Cloud. The Commercial Cloud suite includes tools like Veeva CRM, which streamlines customer relationship management for life sciences companies, and Veeva Vault PromoMats, which manages promotional content and digital assets. Veeva Crossix provides advanced analytics for pharmaceutical brands, while Veeva OpenData offers robust customer reference data solutions. Additionally, Veeva Link and Veeva Compass deliver real-time intelligence and longitudinal patient data, respectively, giving companies deeper insights into market dynamics and patient outcomes.

The Development Cloud focuses on clinical, regulatory, quality, and safety functions. Products like Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality provide end-to-end solutions for clinical trials, regulatory submissions, and safety monitoring. Veeva QualityOne and Veeva RegulatoryOne further enhance quality management and regulatory compliance, while Veeva Claims streamlines product and marketing claims management. These tools are mission-critical for life sciences companies navigating the complexities of drug development and regulatory oversight.

Beyond its software offerings, Veeva provides a range of professional services, including implementation, data migration, and systems integration. These services ensure seamless adoption of its solutions, a key differentiator in an industry where integration and compliance challenges are significant. The company also offers training and managed services, further supporting its clients’ ability to derive maximum value from its platform.

From a financial perspective, Veeva Systems operates with a market capitalization of approximately $38.5 billion, reflecting its strong market position and growth trajectory. The company’s P/E ratio of 58.68 and forward P/E of 33.44 indicate investor confidence in its ability to sustain high growth rates. With a price-to-sales ratio of 14.95, Veeva is valued at a premium, a testament to its leadership in a high-margin, mission-critical software niche.

Veeva’s focus on compliance

Additional Sources for VEEV Stock

VEEV Stock Overview

Market Cap in USD 38,337m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2013-10-16

VEEV Stock Ratings

Growth 5y 24.0%
Fundamental 75.3%
Dividend 0.0%
Rel. Strength Industry -0.2
Analysts 4/5
Fair Price Momentum 201.16 USD
Fair Price DCF 104.67 USD

VEEV Dividends

No Dividends Paid

VEEV Growth Ratios

Growth Correlation 3m 46%
Growth Correlation 12m 56.3%
Growth Correlation 5y -38.9%
CAGR 5y 14.10%
CAGR/Max DD 5y 0.25
Sharpe Ratio 12m -0.64
Alpha -9.42
Beta 0.91
Volatility 32.55%
Current Volume 903.6k
Average Volume 20d 1247.2k
What is the price of VEEV stocks?
As of March 15, 2025, the stock is trading at USD 234.06 with a total of 903,577 shares traded.
Over the past week, the price has changed by -5.16%, over one month by +0.03%, over three months by +4.17% and over the past year by +0.68%.
Is Veeva Systems a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Veeva Systems (NYSE:VEEV) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 75.25 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VEEV as of March 2025 is 201.16. This means that VEEV is currently overvalued and has a potential downside of -14.06%.
Is VEEV a buy, sell or hold?
Veeva Systems has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy VEEV.
  • Strong Buy: 13
  • Buy: 8
  • Hold: 10
  • Sell: 0
  • Strong Sell: 1
What are the forecast for VEEV stock price target?
According to ValueRays Forecast Model, VEEV Veeva Systems will be worth about 223 in March 2026. The stock is currently trading at 234.06. This means that the stock has a potential downside of -4.71%.
Issuer Forecast Upside
Wallstreet Target Price 266.8 14%
Analysts Target Price 267.5 14.3%
ValueRay Target Price 223 -4.7%